Exscientia Ltd ADR Analysis
Exscientia Ltd ADR is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Exscientia delisted stock analysis is to determine its intrinsic value, which is an estimate of what Exscientia Ltd ADR is worth, separate from its market price. There are two main types of Exscientia's stock analysis: fundamental analysis and technical analysis.
The Exscientia stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Exscientia's ongoing operational relationships across important fundamental and technical indicators.
Exscientia |
Exscientia Stock Analysis Notes
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Exscientia ADR has Price/Earnings To Growth (PEG) ratio of 0.1. The entity recorded a loss per share of 1.51. The firm had not issued any dividends in recent years. Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people. To learn more about Exscientia Ltd ADR call CBE DPHIL at 44 18 6581 8941 or check out https://www.exscientia.ai.Exscientia ADR Investment Alerts
Exscientia ADR is not yet fully synchronised with the market data | |
Exscientia ADR has some characteristics of a very speculative penny stock | |
Exscientia ADR has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 20.08 M. Net Loss for the year was (145.96 M) with profit before overhead, payroll, taxes, and interest of 10.25 M. | |
Exscientia Ltd ADR currently holds about 601.89 M in cash with (117.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.91. | |
Roughly 26.0% of the company shares are held by company insiders |
Exscientia ADR Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Exscientia previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of March 2024 Upcoming Quarterly Report | View | |
22nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Exscientia Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 633.18 M.Exscientia Outstanding Bonds
Exscientia issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Exscientia ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Exscientia bonds can be classified according to their maturity, which is the date when Exscientia Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
EXR 39 01 APR 29 Corp BondUS30225VAH06 | View | |
EXR 255 01 JUN 31 Corp BondUS30225VAF40 | View | |
EXR 235 15 MAR 32 Corp BondUS30225VAG23 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Exscientia to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |